secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2026-09-01T10:47:19+00:00
Accession:  0001628280-26-059697
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q1 FY27 revenue up 13.7% to $9.76B; raises FY27 guidance
------------------------------------------------------------------

- Q1 revenue $9.756B, +13.7% reported and organic; GAAP EPS $1.14, non-GAAP EPS $1.45.
- Raises FY27 organic revenue growth to 7.25-7.75% (from 6.75-7.25%) and non-GAAP EPS to $5.94-6.00.
- Cardiovascular +18.9% organic, Neuroscience +9.3%, Medical Surgical +10.2%, Diabetes +14.9%.
- Extra fiscal week added ~$570M to Q1 organic growth; completed acquisitions of Scientia Vascular and SPR Therapeutics.
- Announced strategic investments in Pi-Cardia and Cornerstone Robotics; FDA clearance for Touch Surgery Aide.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/0001628280-26-059697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/mdt-20260901.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-059697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer